Key facts
- It has raised $2.5M across 2 recorded rounds; the latest was Seed Round ($432K) in Feb 2026.
- Notable investors include US National Science Foundation, Springboard Enterprises, GrowthX Capital, TEDCO, Tampa Bay Wave — 9 tracked in total.
- CurieDx has filed 1 Form D with the SEC, most recently Mar 2026 ($432K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for CurieDx
Funding rounds
2 roundsAbout CurieDx
Developer of artificial intelligence-based medical imaging software designed for remote disease screening using smartphone images. The company's platform enables users to capture images through a mobile device, securely upload and process the data using machine learning and computer vision models, generate preliminary screening predictions for conditions such as strep throat and other infections, and share results with telehealth clinicians through integrated digital health workflows, enabling telehealth providers and patients to conduct preliminary illness screening, support remote clinical assessment, and facilitate faster medical consultation without requiring immediate in-person diagnostic testing.
- Industry
- Decision/Risk Analysis
- Sector
- Healthcare
- HQ
- Baltimore, MD, United States
- Founded
- 2021
- Employees
- 6
- Website
- curiedx.com/
- Ownership
- Privately Held (backing)
CurieDx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CurieDx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CurieDx in its N-PORT filings yet. We sweep new filings monthly.